Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Healthy females, pregnant with a boy, generate immune responses against male-specific minor histocompatibility (HY) antigens. The clinical importance of these responses is evident in stem cell transplantation. Birth of a boy prior to a series of miscarriages reduces the chance of a subsequent live birth. This study explores the putative impact of known HY-presenting HLA alleles on future pregnancy outcome in women with at least three consecutive miscarriages following a birth [secondary recurrent miscarriage (SRM)]. HLA-A, -B, -DRB1, DRB3-5 and DQB1 genotyping was performed in 358 SRM patients and in 203 of their children born prior to the miscarriages. The subsequent live birth in women with boys prior to the miscarriages compared with girls is lower in women with HY-restricting HLA class II alleles [odds ratio (OR): 0.17 (0.1-0.4), P = 0.0001]. One HY-restricting HLA class II allele in women with firstborn boys significantly reduces the chances of a live birth [OR: 0.46 (0.2-0.9), P = 0.02]. Two HY-restricting HLA class II alleles further reduced this chance [OR: 0.21 (0.1-0.7), P = 0.02]. HY-restricting HLA class II did not reduce the chances of a live birth in SRM women with firstborn girls. HY-restricting HLA class II alleles are associated with a decreased chance of a live birth in SRM women with firstborn boys. These findings strongly indicate an aberrant maternal immune reaction against fetal HY-antigens in SRM. The results may shed light on the as-yet unknown immunological causes of SRM and may help understand the successful maternal acceptance of the fetal semi-allograft.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum
Bianchi, D. W., Zickwolf, G. K., Weil, G. J., Sylvester, S., & DeMaria, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.705 · Cited by 1,264
Cited by
ESHRE guideline: recurrent pregnancy loss
The ESHRE Guideline Group on RPL, Bender Atik, R., Christiansen, O. B., Elson, J., Kolte, A. M., Lewis, S., Middeldorp, S., Nelen, W., Peramo, B., Quenby, S., et al. (2018) · Human Reproduction Open · doi:10.1093/hropen/hoy004 · Cited by 1,002
Self-citationNew insights into mechanisms behind miscarriage
Larsen, E. C., Christiansen, O. B., Kolte, A. M., & Macklon, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-154 · Cited by 603
Self-citationThe Human Placental Sexome Differs between Trophoblast Epithelium and Villous Vessel Endothelium
Cvitic, S., Longtine, M. S., Hackl, H., Wagner, K., Nelson, M. D., Desoye, G., & Hiden, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079233 · Cited by 127
Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art
Vomstein, K., Feil, K., Strobel, L., Aulitzky, A., Hofer-Tollinger, S., Kuon, R.-J., & Toth, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040869 · Cited by 113
Nielsen, H. S., Steffensen, R., Lund, M., Egestad, L., Mortensen, L. H., Andersen, A. M. N., Lidegaard, O., & Christiansen, O. B. (2010) · Human Reproduction · doi:10.1093/humrep/deq091 · Cited by 61
“DNA extraction and HLA typing is described in detail elsewhere (Nielsen et al., 2009).”
MethodSelf-citationImmunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss: What Is Real and What Is Not?
WANG, N. F., KOLTE, A. M., LARSEN, E. C., NIELSEN, H. S., & CHRISTIANSEN, O. B. (2016) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000215 · Cited by 43
“Among RPL patients with a first-born boy, maternal carriage of one of the alleles, HLA-DRB1*15, HLADQB1*0501/2, and HLA-DRB3*0301, reduces the chance of a live birth by 22% comparedwith patients not carrying these alleles.(56) These alleles (HY-restricting class II HLA alleles) are known to present peptides derived fr…”
BackgroundSelf-citation
Metadata
- Authors
- Nielsen, H. S., Steffensen, R., Varming, K., Van Halteren, A. G. S., Spierings, E., Ryder, L. P., Goulmy, E., & Christiansen, O. B.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-02-17
- Volume
- 18
- Issue
- 9
- Pages
- 1684-1691
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2145074785
- Cited by
- 74
- References
- 1
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.